India's drug regulator has allowed the AstraZeneca Covid-19 vaccine to be used for up to nine months from its manufacture date, as opposed to the prescribed six months, according to a document reviewed by Reuters and a source. The approval, given to a licensed version of the drug made by Serum Institute of India could help minimise vaccine wastage and improve inoculation drive.source https://timesofindia.indiatimes.com/india/india-extends-shelf-life-of-astrazeneca-vaccine-report/articleshow/81760610.cms
Comments
Post a Comment